Naltrexone augments the effects of nicotine replacement therapy in female smokers (Q46398235)

21 December 2017

title

Naltrexone augments the effects of nicotine replacement therapy in female smokers (English)

1 reference

21 December 2017

nicotine replacement therapy

main subject

naltrexone

0 references

nicotine

0 references

1 reference

based on heuristic

inferred from title

author

Kimberly Frost-Pineda

series ordinal

2

object named as

Kimberly Frost-Pineda

1 reference

21 December 2017

Joanne A Byars

1

1 reference

21 December 2017

William S Jacobs

series ordinal

3

1 reference

21 December 2017

Mark S Gold

series ordinal

4

1 reference

21 December 2017

publication date

1 January 2005

1 reference

21 December 2017

Journal of Addictive Diseases

published in

1 reference

21 December 2017

volume

24

1 reference

21 December 2017

issue

2

1 reference

21 December 2017

page(s)

49-60

1 reference

21 December 2017

The effect of age, weight, and lifestyle factors on calcaneal quantitative ultrasound: the ESOPO study.

cites work

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N02_05

Effects of smoking on prostacyclin formation and platelet aggregation in users of oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N02_05

Changes in smoking status affect women more than men: results of the Lung Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N02_05

Gender, social pressure, and smoking cessations: the Community Intervention Trial for Smoking Cessation (COMMIT) at baseline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N02_05

Gender differences in the psychological determinants of cigarette smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N02_05

Gender differences in quit rates following smoking cessation with combination nicotine therapy: Influence of baseline smoking behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N02_05

Gender and the social context of smoking behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N02_05

Gender differences in the outcome of an unaided smoking cessation attempt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N02_05

The Modified Reasons for Smoking Scale: factorial structure, gender effects and relationship with nicotine dependence and smoking cessation in French smokers*

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N02_05

Psychosocial predictors of different stages of cigarette smoking among high school students

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N02_05

Tobacco smoking and nicotine dependence: biological basis for pharmacotherapy from nicotine to treatments that prevent relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N02_05

Gender and determinants of smoking cessation: a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N02_05

Gender differences among smokers and quitters in the Working Well Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N02_05

Pharmacogenetic investigation of smoking cessation treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N02_05

Naltrexone, opiate addiction, and endorphins

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N02_05

The sequential use of clonidine and naltrexone in the treatment of opiate addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N02_05

Role of naltrexone in initial smoking cessation: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N02_05

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N02_05

Efficacy of a nicotine lozenge for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N02_05

Quantitative immunolocalization of mu opioid receptors: regulation by naltrexone

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N02_05

Endogenous opioids and smoking: a review of progress and problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N02_05

Naltrexone blockade of nicotine effects in cigarette smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N02_05

The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N02_05

Gender differences in drug effects: implications for anesthesiologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N02_05

Gender and age influences on human brain mu-opioid receptor binding measured by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N02_05

Effect of chronic alcohol consumption on the activity of the hypothalamic-pituitary-adrenal axis and pituitary beta-endorphin as a function of alcohol intake, age, and gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N02_05

21 January 2018

Identifiers

DOI

10.1300/J069V24N02_05

1 reference

21 December 2017

PubMed ID

15784523

1 reference

21 December 2017